Literature DB >> 17444863

Clinical analysis of primary duodenal adenocarcinoma: an 11-year experience.

Fu-Chih Hung1, Chung-Mou Kuo, Seng-Kee Chuah, Chung-Huang Kuo, Yaw-Sen Chen, Sheng-Nan Lu, Chi-Sin Chang Chien.   

Abstract

BACKGROUND AND AIM: The impact of obstructive jaundice (OJ) complicated by primary duodenal adenocarcinoma (PDA) on survival, and its treatment options, has rarely been mentioned in literature. The aim of the present study was to review the clinical features of PDA patients in an attempt to determine the prognostic factors and the influence of OJ on survival.
METHODS: From May 1994 to February 2005, all duodenal malignancies treated at Kaohsiung Chang Gung Memorial Hospital were reviewed. Preliminary findings were made on a total of 116 duodenal adenocarcinoma (DA) cases. After excluding metastatic DA and the papilla of Vater cancer, 23 patients (19.8%), confirmed as having PDA, were enrolled.
RESULTS: Among the 23 predominantly male patients with a mean age of 68 years, abdominal pain was the most common symptom. Major tumor origin was the second portion, and the predominantly cytological feature was moderate differentiation. Tumor-node-metastasis (TNM) cancer stage IV accounted for 47.8% of the patients, and cancer-directed surgeries (CDS) were performed on 11 patients. Seven patients experienced complications due to OJ, which could be a sign of grave prognosis predicting survival of less than 1 year. Four of the patients received internal or external biliary drainage before CDS or palliative surgeries. Cigarette smoking, cytology, TNM stage, aspartate aminotransferase (AST), OJ, and CDS were significant factors of overall survival in a univariate analysis. The independent predictors of long-term survival were CDS, TNM stage, cytology, cigarette smoking, and AST using the Cox proportional hazard model.
CONCLUSION: PDA patients who did not smoke and who were eligible for and received CDS had better prognostic outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17444863     DOI: 10.1111/j.1440-1746.2007.04935.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  14 in total

1.  Postoperative morbidity is an additional prognostic factor after potentially curative pancreaticoduodenectomy for primary duodenal adenocarcinoma.

Authors:  Giuseppe Malleo; Alfredo Tonsi; Giovanni Marchegiani; Andrea Casarotto; Salvatore Paiella; Giovanni Butturini; Roberto Salvia; Claudio Bassi
Journal:  Langenbecks Arch Surg       Date:  2012-07-17       Impact factor: 3.445

2.  Clinical and endoscopic findings to assist the early detection of duodenal adenoma and adenocarcinoma.

Authors:  Juntaro Matsuzaki; Hidekazu Suzuki; Masayuki Shimoda; Hideki Mori; Seiichiro Fukuhara; Sawako Miyoshi; Tatsuhiro Masaoka; Yasushi Iwao; Yae Kanai; Takanori Kanai
Journal:  United European Gastroenterol J       Date:  2018-12-03       Impact factor: 4.623

3.  Clinicopathological characteristics and survival analysis of primary duodenal cancers: a 14-year experience in a tertiary centre in South China.

Authors:  Shenghong Zhang; Yi Cui; Bihui Zhong; Weiwei Xiao; Xiaorong Gong; Kang Chao; Minhu Chen
Journal:  Int J Colorectal Dis       Date:  2010-10-08       Impact factor: 2.571

4.  Suitable closure for post-duodenal endoscopic resection taking medical costs into consideration.

Authors:  Hirohito Mori; Maki Ayaki; Hideki Kobara; Shintaro Fujihara; Noriko Nishiyama; Tae Matsunaga; Tatsuo Yachida; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

5.  The surgical treatment and outcome for primary duodenal adenocarcinoma.

Authors:  Shao-liang Han; Jun Cheng; Hong-zhong Zhou; Qi-Qiang Zeng; Sheng-Hong Lan
Journal:  J Gastrointest Cancer       Date:  2009-06-10

6.  Duodenal Signet Ring Cell Carcinoma in a Celiac Patient.

Authors:  Franco Pisello; Girolamo Geraci; Francesco Li Volsi; Francesca Stassi; Giuseppe Modica; Carmelo Sciumè
Journal:  Case Rep Gastroenterol       Date:  2009-04-10

7.  Adenocarcinoma of the third and fourth portions of the duodenum: The capsule endoscopy value.

Authors:  Feliciano Chanana Paquissi; Ana Henriqueta Filipe Bunga Pimentel Lima; Maria de Fátima do Nascimento Vieira Lopes; Francisco Viamontes Diaz
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

8.  GNAS-mutated carcinoma arising from gastric foveolar metaplasia in the duodenum after 9 years of observation.

Authors:  Yasumasa Matsuo; Hiroyuki Yamamoto; Yoshinori Sato; Ritsuko Oikawa; Tadateru Maehata; Takashi Fujino; Naohisa Yahagi; Hiroshi Yasuda; Masayuki Takagi; Fumio Itoh
Journal:  Clin J Gastroenterol       Date:  2018-03-31

9.  Prognostic factors associated with survival in patients with primary duodenal adenocarcinoma.

Authors:  Woo Chul Chung; Chang Nyol Paik; Sung Hoon Jung; Kang-Moon Lee; Sang Woo Kim; U-Im Chang; Jin Mo Yang
Journal:  Korean J Intern Med       Date:  2011-03-02       Impact factor: 2.884

10.  A Case of Adenocarcinoma of the Duodenum Arising from Brunner's Gland.

Authors:  Keiko Kamei; Takeo Yasuda; Takuya Nakai; Yoshifumi Takeyama
Journal:  Case Rep Gastroenterol       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.